{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:09:32Z","timestamp":1791360572363,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key Programs in Science and Technology-Discovery and Development of New Drugs with High Clinical Impact","award":["2012ZX09103101-004"],"award-info":[{"award-number":["2012ZX09103101-004"]}]},{"name":"Guangdong Provincial Programs for Achieving Core Technological Breakthroughs in Strategic Emerging Industries","award":["2012A080800010"],"award-info":[{"award-number":["2012A080800010"]}]},{"name":"Shenzhen Municipal Programs for the Research and Development of Technologies","award":["JSA201105090126A"],"award-info":[{"award-number":["JSA201105090126A"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.intimp.2019.03.015","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:26:42Z","timestamp":1552436802000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparison of anti-atopic dermatitis activities between DHMEQ and tacrolimus ointments in mouse model without stratum corneum"],"prefix":"10.1016","volume":"71","author":[{"given":"Huan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.03.015_bb0005","doi-asserted-by":"crossref","unstructured":"De Vuyst E, Salmon M, Evrard C, et al. Atopic dermatitis studies through in vitro models. Front. Med. 2017; 4: 119.","DOI":"10.3389\/fmed.2017.00119"},{"issue":"3","key":"10.1016\/j.intimp.2019.03.015_bb0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1185\/03007990903512156","article-title":"Atopic dermatitis: a review of topical treatment options","volume":"26","author":"Simpson","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.intimp.2019.03.015_bb0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jep.2015.02.040","article-title":"Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC\/Nga murine model of atopic dermatitis","volume":"165","author":"Park","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0020","first-page":"1","article-title":"Silkworm dropping extract ameliorate trimellitic anhydride-induced allergic contact dermatitis by regulating Th1\/Th2 immune response","volume":"26","author":"Choi","year":"2018","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.intimp.2019.03.015_bb0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12906-017-1584-8","article-title":"Effects of Angelicae dahuricae Radix on 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice model","volume":"17","author":"Ku","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.intimp.2019.03.015_bb0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/1547691X.2012.707700","article-title":"IL-6 deficiency exacerbates skin inflammation in a murine model of irritant dermatitis","volume":"10","author":"Lee","year":"2013","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1067\/mjd.2002.120942","article-title":"Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis","volume":"46","author":"Nghiem","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0040","first-page":"CD009864","article-title":"Topical tacrolimus for atopic dermatitis","volume":"1","author":"Cury Martins","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2019.03.015_bb0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jmii.2014.07.006","article-title":"Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes","volume":"49","author":"Chang","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.intimp.2019.03.015_bb0050","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2147\/IJN.S126210","article-title":"Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities","volume":"12","author":"Wan","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2019.03.015_bb0055","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/j.jaad.2005.04.062","article-title":"Efficacy and safety of tacrolimus ointment treatment for up to 4\u202fyears in patients with atopic dermatitis","volume":"53","author":"Hanifin","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0060","first-page":"239","article-title":"Naturally occurring and synthetic inhibitors of NF-kappaB functions","volume":"15","author":"Umezawa","year":"2000","journal-title":"Anticancer Drug Des."},{"key":"10.1016\/j.intimp.2019.03.015_bb0065","first-page":"248","article-title":"Development of a topical ointment of betamethasone dipropionate loaded nanostructured lipid carrier","volume":"11","author":"Kong","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2019.03.015_bb0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00417-014-2879-9","article-title":"Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1beta in human corneal fibroblasts","volume":"253","author":"Inokawa","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/exd.12685","article-title":"Modulation of HMGB1 translocation and RAGE\/NFkappaB cascade by quercetin treatment mitigates atopic dermatitis in NC\/Nga transgenic mice","volume":"24","author":"Karuppagounder","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.fct.2013.03.039","article-title":"Anti-inflammatory effect of prunetin via the suppression of NF-kappaB pathway","volume":"58","author":"Yang","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbrc.2008.12.065","article-title":"Induction of histidine decarboxylase in macrophages inhibited by the novel NF-kappaB inhibitor (\u2212)-DHMEQ","volume":"379","author":"Suzuki","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2019.03.015_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1016-8478(23)15088-6","article-title":"Molecular design and biological activities of NF-kappaB inhibitors","volume":"14","author":"Umezawa","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2019.03.015_bb0095","first-page":"713","article-title":"DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells","volume":"29","author":"Nishimura","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2567.2007.02755.x","article-title":"DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type 1 cytokines, and blocks maturation of dendritic cells","volume":"124","author":"Nishioka","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2019.03.015_bb0105","doi-asserted-by":"crossref","unstructured":"Nishio H, Yaguchi T, Sugiyama J, et al. Immunosuppression through constitutively activated NF-kappaB signalling in human ovarian cancer and its reversal by an NF-kappaB inhibitor. Br. J. Cancer 2014; 110:2965\u20132974.","DOI":"10.1038\/bjc.2014.251"},{"key":"10.1016\/j.intimp.2019.03.015_bb0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08923973.2017.1312436","article-title":"External application of NF-kappaB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB\/OX in BALB\/c mice","volume":"39","author":"Jiang","year":"2017","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1398-9995.2010.02483.x","article-title":"Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation","volume":"66","author":"Hong","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2019.03.015_bb0120","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jep.2012.11.026","article-title":"Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis","volume":"145","author":"Hwang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/907016","article-title":"Anti-inflammatory effect of qingpeng ointment in atopic dermatitis-like murine model","volume":"2013","author":"Li","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2019.03.015_bb0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/DER.0000000000000118","article-title":"Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis","volume":"26","author":"Chia","year":"2015","journal-title":"Dermatitis"},{"key":"10.1016\/j.intimp.2019.03.015_bb0135","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1592\/phco.27.7.1020","article-title":"Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis","volume":"27","author":"Munzenberger","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.intimp.2019.03.015_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11597780-000000000-00000","article-title":"Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis","volume":"13","author":"Frankel","year":"2012","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0150","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.jaad.2005.04.059","article-title":"The efficacy and safety of tacrolimus ointment: a clinical review","volume":"53","author":"Beck","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2004.06269.x","article-title":"The role of topical calcineurin inhibitors in atopic dermatitis","volume":"151","author":"Alomar","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.0022-202X.2005.23754.x","article-title":"Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis","volume":"125","author":"Rubins","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0165","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/jid.2015.117","article-title":"Capsiate inhibits DNFB-induced atopic dermatitis in NC\/Nga mice through mast cell and CD4+ T-cell inactivation","volume":"135","author":"Lee","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0170","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0091-6749(97)70276-8","article-title":"The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells","volume":"100","author":"Punnonen","year":"1997","journal-title":"T J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2019.03.015_bb0175","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpge.2015.04.001","article-title":"Association between IL-4 and IL-6 expression variants and gastric cancer among Portuguese population","volume":"22","author":"Sampaio","year":"2015","journal-title":"GE Port. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2249.2011.04475.x","article-title":"Dehydroxymethylepoxyquinomicin (DHMEQ) can suppress tumour necrosis factor-\u03b1 production in lipopolysaccharide-injected mice, resulting in rescuing mice from death in vivo","volume":"11","author":"Shimo","year":"2011","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2019.03.015_bb0190","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1167\/iovs.06-1473","article-title":"Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappa B pathway","volume":"48","author":"Nagai","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.intimp.2019.03.015_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/ForumImmunDisTher.2013008314","article-title":"Peritoneal NF-\u03baB as a possible molecular target for suppression of various cancers and inflammation","volume":"4","author":"Umezawa","year":"2013","journal-title":"Forum Immunopathol. Dis. Ther."},{"key":"10.1016\/j.intimp.2019.03.015_bb0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.biopha.2008.05.003","article-title":"Inhibition of inflammatory mediator secretion by (\u2212)-DHMEQ in mouse bone marrow-derived macrophages","volume":"63","author":"Suzuki","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2019.03.015_bb0205","first-page":"1","article-title":"Dehydroxymethylepoxyquinomicin suppresses atopic dermatitis-like lesions in a stratum corneum-removed murine model through NF-\u03baB inhibition","volume":"6","author":"Jiang","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000371419","article-title":"Inhibition of MMP-2-mediated mast cell invasion by NF-\u03baB inhibitor DHMEQ in mast cells","volume":"166","author":"Noma","year":"2015","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.intimp.2019.03.015_bb0215","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1167\/iovs.09-4030","article-title":"Amelioration of experimental autoimmune uveoretinitis with nuclear factor-\u03baB inhibitor dehydroxy methyl epoxyquinomicin in mice","volume":"4","author":"Iwata","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.intimp.2019.03.015_bb0220","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1021\/jm8006245","article-title":"Inactivation of nuclear factor kappa B components by covalent binding of (\u2212)-dehydroxymethylepoxyquinomicin to specific cysteine residues","volume":"51","author":"Yamamoto","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2019.03.015_bb0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3727\/096504010X12767359113721","article-title":"Efficient cellular uptake of the novel NF-\u03baB inhibitor (\u2212)-DHMEQ and irreversible inhibition of NF-\u03baB in neoplastic cells","volume":"18","author":"Shimada","year":"2010","journal-title":"Oncol. Res."},{"key":"10.1016\/j.intimp.2019.03.015_bb0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1540-9740.2007.06485.x","article-title":"Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interactions, dosages, and side effects: part I","volume":"7","author":"Sehgal","year":"2008","journal-title":"Skin Med."},{"key":"10.1016\/j.intimp.2019.03.015_bb0235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpharm.2010.07.008","article-title":"Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis","volume":"398","author":"Pople","year":"2010","journal-title":"Int. J. Pharm."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918306167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918306167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:11:46Z","timestamp":1761585106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918306167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":47,"alternative-id":["S1567576918306167"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.03.015","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of anti-atopic dermatitis activities between DHMEQ and tacrolimus ointments in mouse model without stratum corneum","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}